Delivery Order SPE2DB24D6039-SPE2DB25FLEAE

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,948.34, is a delivery order contract with a firm fixed price pricing type. The contract provides for the delivery of PROCTOFOAM 10GM 1S medical supplies, with a completion date of January 28, 2025. The contract is not designated with a set-aside requirement, indicating open...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,807.64 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of July 12, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,556.00 Firm Fixed Price Delivery Order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184900 - PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $1,215.60 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.04, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.60 firm fixed price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The contract has a completion date of February 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a variety of medical products and supplies. The contract, valued at up to $1,668.48, is a Delivery Order for "PROCTOFOAM-HC 1%-1% FOAM 10GM" with a completion date of June 11, 2024. The contract has a Firm Fixed Price pricing type and was awarded on a full and open competition basis without any set-aside designation....
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,752.15 contract is for the provision of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
  • SPE2DB24D6039
    Indefinite Delivery Contract
  • SPE2DB24D6039-SPE2DB25FLEAE
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. is a Delivery Order with a Firm Fixed Price valued at $1,761.96. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical supply item, with a completion date of January 10, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/10/25, 11:48 AM